Weight Loss Drug Developer Files For Liquidation
Weight loss drug developer Gelesis Inc. has filed for Chapter 7 liquidation in a Delaware bankruptcy court with over $44 million in debt in the wake of a canceled merger with...To view the full article, register now.
Already a subscriber? Click here to view full article